Long-term effects of novel biodegradable, polymer-coated, sirolimus-eluting stents on neointimal formation in a porcine coronary model

International Heart Journal

Volumn 50, Issue 6, 2009, Pages 811-822

  Peng, Hong Yu ^a   Chen, Ming ^a   Zheng, Bo ^a   Wang, Xin Gang ^a   Huo, Yong ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Bioabsorbable; PLGA; Polymer; Restenosis; Sirolimus eluting stents

Indexed keywords

CHROMIUM; COBALT; COPOLYMER; POLYACTIC CO GLYCOLIC ACID; PROTEIN P27; RAPAMYCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; CORONARY ARTERY; DRUG ELUTING STENT; HISTOPATHOLOGY; HYPERPLASIA; IMPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ABSORBABLE IMPLANTS; ANIMALS; CORONARY VESSELS; DRUG-ELUTING STENTS; POLYMERS; SIROLIMUS; SWINE; TUNICA INTIMA;

EID: 74049159963     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.50.811     Document Type: Article

References (24)

1. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-23.
2. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-31.
3. Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005; 112: 270-8.
4. Lim SY, Jeong MH, Hong SJ, et al. Inflammation and delayed endothelization with overlapping drugeluting stents in a porcine model of in-stent restenosis. Circ J 2008; 72: 463-8.
5. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.
6. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004; 109: 701-5.
7. Commandeur S, van Beusekom HM, van der Giessen WJ. Polymers, drug release, and drug-eluting stents. J Interv Cardiol 2006; 19: 500-6. (Review)
8. Bünger CM, Grabow N, Sternberg K, et al. Sirolimus-eluting biodegradable poly-L-lactide stent for peripheral vascular appUcation: a preliminary study in porcine carotid arteries. J Surg Res 2007; 139: 77-82.
9. Han Y, Jing Q, Chen X, et al. Long-term chnical, angiographic, and intravascular ultrasound outcomes of biodegradable polymer-coated sirolimus-eluting stents. Catheter Cardiovasc Interv 2008; 72: 177-83.
10. Buszman P, Trznadel S, Milewski K, et al. Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: a prospective multicenter registry. Catheter Cardiovasc Interv 2008; 71: 51-7.
11. Alexis F, Venkatraman SS, Rath SK, Boey F. In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices. J Control Release 2004; 98: 67-74.
12. Lowe HC, Schwartz RS, Mac Neill BD, et al. The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents. Catheter Cardiovasc Interv 2003; 60: 515-23. (Review)
13. Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992; 19: 267-74.
14. Suzuki T, Kopia G, Hayashi S, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001; 104: 1188-93.
15. Deiner C, Loddenkemper C, Rauch U, et al. Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosis. Cardiovasc Revasc Med 2007; 8: 94-8.
16. Carter AJ, Aggarwal M, Kopia GA, et al. Long-term effects of polymer-based, slow-release, sirolimuseluting stents in a porcine coronary model. Cardiovasc Res 2004; 63: 617-24.
17. Bishop GG, McPherson JA, Sanders JM, et al. Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation 2001; 103: 1906-11.
18. Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002; 105: 2974-80.
19. Lincoff AM, Furst JG, Ellis SG, Tuch RJ, Topol EJ. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol 1997; 29: 808-16.
20. van der Giessen WJ, Lincoff AM, Schwartz RS, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996; 94: 1690-7.
21. Fuke S, Maekawa K, Kawamoto K, et al. Impaired endothelial vasomotor function after sirolimuseluting stent implantation. Circ J 2007; 71: 220-5.
22. Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Tbromb Vase Biol 2007; 27: 1500-10. (Review)
23. Gallo R, Padurean A, Jayaraman T, et al. Inhibition of intimai thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 1999; 99: 2164-70.
24. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Müller KM. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 2000; 35: 157-63.